Clinical Trials Directory

Trials / Completed

CompletedNCT00472446

Superficial, Cervical Block in Thyroid Surgery, a Randomized Controlled Trial

Impact and Cost Efficiency of Bilateral, Superficial Cervical Block in Thyroid Surgery Under General Anesthesia

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
183 (actual)
Sponsor
Cantonal Hospital of St. Gallen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study investigates the impact on post-operative pain of the superficial cervical block with bupivacaine combined with subcutaneous infiltration of the incisional area in thyroid surgery under general anesthesia. In addition, cost savings using the cervical block are evaluated (due to reduced length of hospital stay). The study is prospective, randomized, double blind, and placebo-controlled. The study is performed at the Department of Surgery, Cantonal Hospital of St. Gallen.

Conditions

Interventions

TypeNameDescription
DRUGbilateral superficial cervical block10 ml of 5% bupivacaine (Carbostesin®) was used for each side. Along the cranial dorsal edge of the sternocleidomastoid muscle, three deposits of approximately 2.5 ml were injected to anaesthetize the cervical plexus with its nervus transversus colli. To anaesthetize the region of the planned skin incision, the remaining 2·5 ml was injected subcutaneously on each side.
DRUGplacebo bilateral superficial cervical block10 ml of saline (the carrier of bupivacaine in the experimental treatment) was used for each side. Along the cranial dorsal edge of the sternocleidomastoid muscle, three deposits of approximately 2.5 ml were injected to anaesthetize the cervical plexus with its nervus transversus colli. To anaesthetize the region of the planned skin incision, the remaining 2·5 ml was injected subcutaneously on each side.

Timeline

Start date
2006-01-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2007-05-11
Last updated
2016-09-15
Results posted
2016-09-15

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00472446. Inclusion in this directory is not an endorsement.